PMID: 25614468
Question: Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging?
Correct Answer: no

======================= Launch the MCC process =======================
PMID: 25614468
Question: Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content**: The primary question investigates whether magnetic resonance imaging (MRI) is beneficial for preoperative locoregional staging of gastric cancer.
- **Key Information**: The study compares the diagnostic performance of MRI against multidetector computed tomography (MDCT) and endoscopic ultrasonography (EUS) in staging gastric cancer, focusing on aspects like sensitivity, specificity, and overall accuracy.

**2. Evidence Evaluation**
- **Research Results**:
  - **T Staging**: EUS demonstrated higher sensitivity (94%) compared to MRI (76%) and MDCT (65%). MRI and MDCT showed higher specificity than EUS.
  - **N Staging**: EUS again showed higher sensitivity (92%) than MRI (73%) and MDCT (69%). MDCT had better specificity compared to EUS and MRI.
  - **Overall Conclusion**: The study affirmed the superior roles of EUS and MDCT in staging gastric cancer and found no significant added value of MRI in the clinical setting.
- **Strength and Reliability**: The study was prospective, involved 52 patients with biopsy-proven gastric cancer, and used histopathological findings as a reference. The statistical analysis (McNemar test) adds robustness to the findings.
- **Relevance**: Directly addresses the research question by comparing MRI with established diagnostic methods.

**3. Conclusion**
Based on the study's findings, MRI does not currently offer significant advantages over EUS and MDCT for preoperative locoregional staging of gastric cancer.

**4. Final Answer**
**My final choice is: "no"**
GPT selected: no

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether magnetic resonance imaging (MRI) has a role in preoperative locoregional staging of gastric cancer. The key information to evaluate is whether the study's findings support the clinical utility of MRI compared to other modalities (EUS and MDCT).  

**2. Evidence Evaluation**  
- **T Staging**:  
  - EUS showed higher sensitivity (94%) than MRI (76%) and MDCT (65%), though differences with MRI were not statistically significant (p=0.08).  
  - MDCT and MRI had higher specificity (89–91%) than EUS (60%). However, adding MRI to MDCT or EUS did **not** improve sensitivity.  
- **N Staging**:  
  - EUS had the highest sensitivity (92%), while MDCT had better specificity (81%) than MRI (73%).  
- **Conclusion of the Study**: The abstract explicitly states, *"Our prospective study confirmed the leading role of EUS and MDCT in the staging of gastric cancer and did not prove, at present, the value of the clinical use of MRI."*  

The study’s results indicate that MRI does not outperform EUS or MDCT in critical metrics like sensitivity for T/N staging and does not add significant value when combined with these modalities. The authors explicitly conclude MRI lacks proven clinical utility in this context.  

**3. Conclusion**  
The evidence from this prospective study does not support a role for MRI in preoperative locoregional staging of gastric cancer, as it failed to demonstrate superiority or complementary value compared to EUS and MDCT. The authors directly state MRI’s clinical value is unproven here.  

**4. Final Answer:**  
**My final choice is: "no"**
Qwen selected: no

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether MRI has a role in preoperative locoregional staging of gastric cancer. Key information to evaluate includes comparative diagnostic performance (sensitivity, specificity, accuracy) of MRI versus MDCT and EUS for T (tumor invasion) and N (nodal involvement) staging, as well as the study's conclusion.

**2. Evidence Evaluation**  
- For **T staging**, EUS had the highest sensitivity (94% vs. MRI’s 76% and MDCT’s 65%), while MDCT and MRI had higher specificity (91% and 89% vs. EUS’s 60%).  
- For **N staging**, EUS again showed superior sensitivity (92% vs. MRI’s 69% and MDCT’s 73%), while MDCT had the best specificity (81% vs. MRI’s 73% and EUS’s 58%).  
- The study explicitly states that adding MRI to MDCT or EUS did not significantly improve sensitivity. The authors conclude that MRI lacks proven clinical value in this context compared to EUS and MDCT.  

**3. Conclusion**  
The evidence indicates that MRI does not outperform EUS or MDCT in key diagnostic metrics for gastric cancer staging. The study concludes that MRI’s clinical utility remains unproven, favoring EUS and MDCT as primary modalities. Thus, the answer is **"no"**.

**4. Final Answer**  
**My final choice is: no**
DeepSeek selected: no

Initial consensus: All models selected no